# Cardiovascular Complications of Ibrutinib Therapy

> **NCT05939752** · — · TERMINATED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 8 (actual)

## Conditions studied

- Ibrutinib Treatment

## Interventions

- **OTHER:** ophthalmological examination
- **BIOLOGICAL:** blood test

## Key facts

- **NCT ID:** NCT05939752
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-20
- **Primary completion:** 2025-08-05
- **Final completion:** 2025-08-05
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** premature shutdown due to change in processing line
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939752, "Cardiovascular Complications of Ibrutinib Therapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05939752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*